Advisory Services Network, LLC Blueprint Medicines Corp Transaction History

Advisory Services Network, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$43.96 - $92.84 $10,858 - $22,931	247 New	247 $22,000
Q1 2023 May 17, 2023	SELL	$37.97 - $50.0 $23,199 - $30,550	-611 Reduced 71.8%	240 $10,000
Q4 2022 Feb 13, 2023	BUY	$41.06 - $66.48 $34,942 - $56,574	851 New	851 $37,000
Q3 2021 Nov 05, 2021	SELL	$80.98 - $109.47 $4,049 - $5,473	-50 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$82.78 - $101.0 $4,139 - $5,050	50 New	50 $4,000
Q1 2021 May 24, 2021	SELL	$90.71 - $108.28 $2,812 - $3,356	-31 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$92.08 - $124.48 $6,261 - $8,464	-68 Reduced 68.69%	31 $3,000
Q3 2020 Nov 16, 2020	BUY	$66.45 - $92.7 $6,578 - $9,177	99 New	99 $9,000
Q2 2020 Aug 10, 2020	SELL	$57.09 - $79.27 $4,909 - $6,817	-86 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $4,137 - $7,070	86 New	86 $5,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.